These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4277518)

  • 1. Identification of four MLC-specificities in the dog.
    Grosse-Wilde H; Vriesendorp HM; Wank R; Mempel W; Dechamps B; Honauer U; Baumann P; Netzel B; Kolb HJ; Albert ED
    Tissue Antigens; 1974; 4(3):229-37. PubMed ID: 4277518
    [No Abstract]   [Full Text] [Related]  

  • 2. Serology and genetics of the DL-A system. I. Establishment of specificities.
    Albert ED; Erickson VM; Graham TC; Parr M; Templeton JW; Mickey MR; Thomas ED; Storb R
    Tissue Antigens; 1973; 3(6):417-30. PubMed ID: 4272899
    [No Abstract]   [Full Text] [Related]  

  • 3. Serotyping for MLC gene products. II. ABCIL detection of HLA-D specificities by the "tandem" technique, using multiparous sera before and after absorption with HLA-D homozygous lymphocytes.
    Kovithavongs T; Marchuk L; Schlaut J; Dossetor JB
    Transplant Proc; 1977 Mar; 9(1):445-9. PubMed ID: 141131
    [No Abstract]   [Full Text] [Related]  

  • 4. Definition of MLC specificities in the dog.
    Goldmann SF; Krumbacher K; Schnappauf H; Flad HD
    Transplant Proc; 1975 Sep; 7(3):389-93. PubMed ID: 51523
    [No Abstract]   [Full Text] [Related]  

  • 5. Joint report of 1st International Workshop on Canine Immunogenetics.
    Vriesendorp HM; Westbroek DL; D'Amaro J; van der Does JA; van der Steen GJ; van Rood JJ; Albert E; Bernini L; Bull RW; Cabasson J; Epstein RB; Erikson V; Feltkamp TE; Flad HD; Hammer C; Lang R; Largiadér F; von Loringhoven K; Los W; Meera Khan P; Saison R; Serrou B; Schnappauf H
    Tissue Antigens; 1973; 3(2):145-63. PubMed ID: 4274159
    [No Abstract]   [Full Text] [Related]  

  • 6. MLC results among unrelated can be predicted.
    Jørgensen F; Lamm LU; Kissmeyer-Nielsen F
    Tissue Antigens; 1975 May; 5(4):262-5. PubMed ID: 125470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histocompatibility determinants in multiple sclerosis.
    Jersild C; Dupont B; Fog T; Platz PJ; Svejgaard A
    Transplant Rev; 1975; 22():148-63. PubMed ID: 46643
    [No Abstract]   [Full Text] [Related]  

  • 8. The histocompatibility complex SL-A in the pig. Possible recombination between the regions governing MLR and serology respectively.
    Vaiman M; Haag J; Arnoux A; Nizza P
    Tissue Antigens; 1973; 3(3):204-11. PubMed ID: 4272389
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of possible HL-A haploidentity on renal-graft survival in Eurotransplant.
    Van Hooff JP; Hendriks GF; Schippers HM; Van Rood JJ
    Lancet; 1974 Jun; 1(7867):1130-2. PubMed ID: 4136823
    [No Abstract]   [Full Text] [Related]  

  • 10. MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease.
    Thomsen M; Platz P; Andersen OO; Christy M; Lyngsøoe ; Nerup J; Rasmussen K; Ryder LP; Nielsen LS; Svejgaard A
    Transplant Rev; 1975; 22():125-47. PubMed ID: 46642
    [No Abstract]   [Full Text] [Related]  

  • 11. On the relationship between initiator and effector cells in the response to major tansplantation antigens.
    Howard JC
    Transplant Proc; 1973 Dec; 5(4):1451-6. PubMed ID: 4130057
    [No Abstract]   [Full Text] [Related]  

  • 12. Histocompatibility testing in dogs. II. Leukocyte typing in relation to the mixed lymphocyte culture (MLC) reactivity.
    Goldmann SF; Krumbacher K; Schnappauf HP; Huget RP; Flad HD
    Tissue Antigens; 1975 Apr; 5(3):155-64. PubMed ID: 1135860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint report of the Third International Workshop of Canine Immunogenetics. II. Analysis of the serological typing of cells.
    Bull RW; Vriesendorp HM; Cech R; Grosse-Wilde H; Bijma AM; Ladiges WL; Krumbacher K; Doxiadis I; Ejima H; Templeton J
    Transplantation; 1987 Jan; 43(1):154-61. PubMed ID: 3798556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Typing for MLC determinants by means of LD-homozygous and LD-heterozygous test cells.
    Dupont B; Jersild C; Hansen GS; Nielsen LS; Thomsen M; Svejgaard A
    Transplant Proc; 1973 Dec; 5(4):1543-9. PubMed ID: 4130064
    [No Abstract]   [Full Text] [Related]  

  • 15. One-way nonstimulation in MLC related to DL-A homozygosity.
    Grosse-Wilde H; Baumann P; Netzel B; Kolb HJ; Mempel W; Wank R; Albert ED
    Transplant Proc; 1973 Dec; 5(4):1567-71. PubMed ID: 4130066
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenotypic expression of the main histocompatibility complex (DL-A) in randomly selected mongrel dogs. I. Serologically detectable (SD) DL-A antigens and mixed leukocyte (MLC) reactivity.
    Bachvaroff R; Ozaki A; Cannon FD; Mollen N; Blumenstock DA; Ayvazian JH; Ferrebee JW; Rapaport FT
    Transplant Proc; 1973 Dec; 5(4):1561-5. PubMed ID: 4272818
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of five lymphocyte activating determinants in man.
    Thorsby E; Helgesen A; Rankin B; Möller E; Kaakinen A
    Tissue Antigens; 1975 Sep; 6(3):147-60. PubMed ID: 52910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human major histocompatibility system.
    Thorsby E
    Transplant Rev; 1974; 18():51-129. PubMed ID: 4141523
    [No Abstract]   [Full Text] [Related]  

  • 19. MLC vs CML in a case of T-cell immunodeficiency and ADA deficiency.
    Cohen F
    Birth Defects Orig Artic Ser; 1975; 11(1):486-8. PubMed ID: 125120
    [No Abstract]   [Full Text] [Related]  

  • 20. One-way nonstimulation of mixed leukocyte culture in canine families.
    Schroeder ML; Gluckman E; Storb R; Thomas ED
    Transplant Proc; 1975 Sep; 7(3):395-8. PubMed ID: 51524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.